Clinical Trial Update: Nebulised Heparin in Patients With COVID-19 Pneumonia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for nebulised heparin in COVID-19 pneumonia spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Nebulised heparin (heparin)

Snippet

Sponsor: Lady Reading Hospital, Pakistan | Conditions: COVID-19 Pneumonia | Phase 2, Phase 3 | Status: UNKNOWN